The United States Patent and Trademark Office has issued a patent covering the methods of cancer treatment with Lorus Therapeutics' novel therapy, IL-17E. Treatment methods with IL-17E include single and combination therapy along with ...
Tags: IL-17E, Lorus Therapeutics, Cancer Therapy, US Patent
The Canadian Intellectual Property Office has issued a patent for Lorus Therapeutics' cancer immunotherapy agent, IL-17E. The patent protects the use of IL-17E to treat cancer, including solid tumors such as colon, breast, ovarian, ...
Tags: patent, IL-17E, treatment of cancer